The Safety of NSAIDs in Heart Failure Patients
Links shared publicly online about this topic
The safety of NSAIDs in heart failure patients
cardiologytoday.com — “The safety of NSAIDs in heart failure patients” View full resource at cardiologytoday.com
Most Recently Shared on June 1, 2010 at 1:29 pm By:
The safety of NSAIDs in heart failure patients - Cardiology Today http://bit.ly/9B3PBU
NSAIDs and CHF
theheart.org — “Even commonly used NSAIDs available without prescription can increase risk of death and cardiac events, a new Danish study has found. (Gislason GH et al. Arch Intern Med 2009; 169:141-149.)” View full resource at theheart.org
Most Recently Shared on January 29, 2009 at 11:01 pm By:
More evidence that NSAIDs are harmful to heart-failure patients http://tinyurl.com/b9f6cf
Which NSAID for heart disease patients?
theheart.org — “One of the first large studies to look at the safety of different NSAIDs specifically in patients with heart disease has found that naproxen appears to have better cardiovascular safety than diclofenac, ibuprofen, and higher doses of rofecoxib and celecoxib.” View full resource at theheart.org
Most Recently Shared on May 28, 2009 at 2:03 pm By:
heartwire: Naproxen best NSAID for heart-disease patients http://bit.ly/FOsRm
NSAIDs raise risk of heart disease: Study
news-medical.net — “A new study published online in the British Medical Journal explores the relative safety of non-steroidal anti-inflammatory medications (NSAIDs), commonly used to treat joint and muscle aches and pain and concludes that NSAIDs significantly increase the risk of cardiovascular events in patients who take them regularly.” View full resource at news-medical.net
Most Recently Shared on January 13, 2011 at 8:07 am By:
Stroke News: NSAIDs raise risk of heart disease: Study: A new study published online in the British Medical Jo... http://twurl.nl/6w3tf5
Pfizer heart-failure drug helps milder patients: study
health.yahoo.net — “People with mild heart failure lived longer and fared better by adding Pfizer's drug Inspra to standard medications, a finding that could widely expand use of such drugs in healthier patients, researchers said on Sunday.” View full resource at health.yahoo.net
Most Recently Shared on November 14, 2010 at 7:10 pm By:
Pfizer heart-failure drug helps milder patients: study: People with mild heart failure lived longer and fared be... http://bit.ly/9iXou4
Pfizer heart-failure drug helps milder patients: study
health.yahoo.net — “People with mild heart failure lived longer and fared better by adding Pfizer's drug Inspra to standard medications, a finding that could widely expand use of such drugs in healthier patients, researchers said on Sunday.” View full resource at health.yahoo.net
Most Recently Shared on November 14, 2010 at 7:07 pm By:
Pfizer heart-failure drug helps milder patients: study http://bit.ly/8Ypg0r
NSAID Pain Relievers Raise Heart Risks - Heart Disease and Other Cardiovascular Conditions on MedicineNet.com
medicinenet.com — “Information on heart disease and related cardiovascular conditions includes medications, procedures and tests, symptoms, and treatment.” View full resource at medicinenet.com
Most Recently Shared on January 14, 2011 at 1:52 pm By:
Dronedarone for AF seems safe in stable heart failure
theheart.org — “A post hoc analysis could help alleviate a lingering concern about the drug, which an FDA advisory panel recently recommended for approval.” View full resource at theheart.org
Most Recently Shared on May 16, 2009 at 12:30 pm By:
heartwire: ATHENA data suggest dronedarone for AF is safe in stable heart failure http://bit.ly/QumbE
Studies: Drug, device help treat heart failure
health.yahoo.net — “Millions of people with mild or moderate heart failure got good news Sunday, with studies showing a Pfizer drug and a device from Medtronic can boost survival and cut trips to the hospital by patients having trouble breathing.” View full resource at health.yahoo.net
Most Recently Shared on November 14, 2010 at 3:03 pm By:
Studies show drug, device help treat heart failure http://bit.ly/aHsotm
Studies: Drug, device help treat heart failure
health.yahoo.net — “Millions of people with mild or moderate heart failure got good news Sunday, with studies showing a Pfizer drug and a device from Medtronic can boost survival and cut trips to the hospital by patients having trouble breathing.” View full resource at health.yahoo.net
Most Recently Shared on November 14, 2010 at 2:40 pm By:
Studies show drug, device help treat heart failure http://bit.ly/apuV1I
AHRQ Patient Safety Network
psnet.ahrq.gov — “AHRQ Patient Safety Network” View full resource at psnet.ahrq.gov
Most Recently Shared on December 20, 2010 at 11:48 pm By:
RT @quality1: Assoc found btwn lower safety culture & higher 30-day readmit rates for AMI & heart failure http://ow.ly/3rW31 #ptsafety
Symposier - Nesiritide for Acute Heart Failure
symposier.com — “Uploaded and shared in Youtube by: ElsGlobalMedicalNews --" Results from the 7,000-patient ASCEND-HF trial show that nesiritide was safe for treating patients with acute decompensated heart failure, but on average it only exerted a small dyspnea. Despite that, nesiritide has a role as a second-line agent because of its safety and ability to help certain patients. Read the story: http://bit.ly/evpUhy” View full resource at symposier.com
Most Recently Shared on December 3, 2010 at 11:48 pm By:
Nesiritide for Acute Heart Failure, Results from ASCENT-HF show nesiritide is safe. http://bit.ly/hZkpDY
Cardioxyl Pharmaceuticals Announces Positive Results From First Clinical Study Of CXL-1020 In Heart Failure Patients
medicalnewstoday.com — “Cardioxyl Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing novel therapeutic agents for the treatment of cardiovascular disease, today announced that it has achieved posit” View full resource at medicalnewstoday.com
Most Recently Shared on August 3, 2010 at 5:07 pm By:
Cardioxyl Pharmaceuticals Announces Positive Results From First Clinical Study Of CXL-1020 In Heart Failure Patients http://mnt.to/3GVv
Juventas Therapeutics Enrolling Phase I Clinical Trial Of JVS-100 For Patients With Heart Failure
medicalnewstoday.com — “Juventas Therapeutics, a privately held, clinical-stage regenerative medicine company announced it has started enrolling patients in a Phase I clinical trial for JVS-100 to evaluate safety and eff” View full resource at medicalnewstoday.com
Most Recently Shared on April 6, 2010 at 5:11 pm By:
Juventas Therapeutics Enrolling Phase I Clinical Trial Of JVS-100 For Patients With Heart Failure http://mnt.to/3zRk #pharma #pharmaceutical
Cardiology Medical News about Heart Failure
mdlinx.com — “Safety of Subcutaneous Octreotide in Patients with Sulfonylurea-Induced Hypoglycemia and Congestive Heart Failure” View full resource at mdlinx.com
Most Recently Shared on January 13, 2010 at 10:27 am By:
Cardio: Safety of Subcutaneous Octreotide in Patients with Sulfonylurea-Induced Hypoglycemia and Congestive Heart Failu http://url4.eu/17ITW
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
low sodium foods
Healthy Heart Market - Your Online Low Sodium Food Market
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
Advertisement

